GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Botanix Pharmaceuticals Ltd (ASX:BOT) » Definitions » 12-1 Month Momentum %

Botanix Pharmaceuticals (ASX:BOT) 12-1 Month Momentum %

: 109.68% (As of Today)
View and export this data going back to 1985. Start your Free Trial

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-04-19), Botanix Pharmaceuticals's 12-1 Month Momentum % is 109.68%.

The industry rank for Botanix Pharmaceuticals's 12-1 Month Momentum % or its related term are showing as below:

ASX:BOT's 12-1 Month Momentum % is ranked better than
92.3% of 1480 companies
in the Biotechnology industry
Industry Median: -25.2 vs ASX:BOT: 109.68

Competitive Comparison

For the Biotechnology subindustry, Botanix Pharmaceuticals's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Botanix Pharmaceuticals 12-1 Month Momentum % Distribution

For the Biotechnology industry and Healthcare sector, Botanix Pharmaceuticals's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Botanix Pharmaceuticals's 12-1 Month Momentum % falls into.



Botanix Pharmaceuticals  (ASX:BOT) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Botanix Pharmaceuticals  (ASX:BOT) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Botanix Pharmaceuticals 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Botanix Pharmaceuticals's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Botanix Pharmaceuticals (ASX:BOT) Business Description

Traded in Other Exchanges
Address
661 Newcastle Street, D2, LEEDERVILLE, WA, AUS, 6007
Botanix Pharmaceuticals Ltd is a clinical-stage cannabinoid therapeutics company. The company's focus is the development of safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system - Permetrex for direct skin delivery of active pharmaceuticals in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1308 - Plaque Psoriasis, BTX1204 - Atopic Dermatitis, and BTX 1701 - Mild Acne. The majority of Revenue is Derived from Australia.

Botanix Pharmaceuticals (ASX:BOT) Headlines

No Headlines